Unjoni Ewropea - Malti - EMA (European Medicines Agency)

angelini pharma s.p.a - cenobamate - epilessija - anti-epilettiċi, - adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

stemline therapeutics b.v. - elacestrant - neoplażmi tas-sider - terapija endokrinali - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.